Regen BioPharma, Inc. (RGBPP)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 236.56 Thousand | 235.51 Thousand | 171.19 Thousand | 110 Thousand | 110 Thousand | 100 Thousand |
| Cost of Revenue | 60 Thousand | 50 Thousand | 25 Thousand | - | - | - |
| Gross Profit | 176.56 Thousand | 185.51 Thousand | 146.19 Thousand | 110 Thousand | 110 Thousand | 100 Thousand |
| Operating Expenses | 923.51 Thousand | 575.12 Thousand | 371.96 Thousand | 319.31 Thousand | 866.78 Thousand | 1.52 Million |
| Selling, General and Administrative Expenses | 711.21 Thousand | 299.73 Thousand | 335.26 Thousand | 306.03 Thousand | 821.18 Thousand | 1.15 Million |
| Research and Development Expenses | 212.29 Thousand | 275.38 Thousand | 36.7 Thousand | 13.28 Thousand | 45.6 Thousand | 374.43 Thousand |
| Other Expenses | 1.00 | 62.7 Thousand | 1.00 | - | 1731.00 | -270.19 Thousand |
| Cost and Expenses | 923.51 Thousand | 575.12 Thousand | 371.96 Thousand | 319.31 Thousand | 866.78 Thousand | 1.52 Million |
| Operating Income | -686.95 Thousand | -339.6 Thousand | -200.77 Thousand | -209.31 Thousand | -756.78 Thousand | -1.42 Million |
| Interest Expense | 59.44 Thousand | 209.78 Thousand | 367.02 Thousand | 942.93 Thousand | 1.7 Million | 1.56 Million |
| Income Tax Expense | - | -2.99 Million | 366.79 Thousand | 1.62 Million | 1.7 Million | 3.01 Million |
| Earnings before Tax | 1.15 Million | 2.44 Million | -6.76 Million | 3.41 Million | -2.62 Million | -4.71 Million |
| Net Income | 1.02 Million | 5.43 Million | -7.13 Million | 1.78 Million | -4.32 Million | -4.71 Million |
| Earnings Per Share Basic | 0.26 | 0.15 | -0.00 | 0.00 | -0.00 | -0.13 |
| Earnings Per Share Diluted | 0.29 | 0.15 | -0.00 | 0.00 | -0.00 | -0.13 |
| Weighted Average Shares Outstanding | 3.99 Million | 37.32 Million | 3.01 Billion | 1.4 Billion | 2.07 Billion | 37.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.53 Million | 37.32 Million | 3.01 Billion | 1.4 Billion | 2.07 Billion | 37.32 Million |
| Gross Margin | 0.75 | 0.79 | 0.85 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -3.96 | -1.37 | -1.17 | -1.90 | -6.85 | -16.86 |
| Profit Margin | 4.33 | 23.08 | -41.66 | 16.26 | -39.31 | -47.15 |
| EBITDA | -936.94 Thousand | 2.99 Million | -6.39 Million | 4.56 Million | -753.75 Thousand | -1.68 Million |
| Earnings Before Tax Margin | -2.90 | -1.44 | -1.17 | -1.90 | -6.88 | -14.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 59.06 Thousand | 59.06 Thousand | 59.06 Thousand | 236.56 Thousand | 59.36 Thousand | 59.06 Thousand |
| Cost of Revenue | 22.5 Thousand | 17.21 Thousand | 15 Thousand | 60 Thousand | 15 Thousand | 15 Thousand |
| Gross Profit | 36.56 Thousand | 41.85 Thousand | 44.06 Thousand | 176.56 Thousand | 44.36 Thousand | 44.06 Thousand |
| Operating Expenses | 167.03 Thousand | 160.13 Thousand | 181.84 Thousand | 923.5 Thousand | 118.45 Thousand | 144.22 Thousand |
| Selling, General and Administrative Expenses | 134.53 Thousand | 120 Thousand | 134.31 Thousand | - | 83.11 Thousand | 99.21 Thousand |
| Research and Development Expenses | 32.5 Thousand | 40.13 Thousand | 47.52 Thousand | - | 35.33 Thousand | 45 Thousand |
| Other Expenses | - | - | - | - | 45 Thousand | - |
| Cost and Expenses | 167.03 Thousand | 160.13 Thousand | 181.84 Thousand | 923.5 Thousand | 118.45 Thousand | 144.22 Thousand |
| Operating Income | -107.96 Thousand | -101.07 Thousand | -122.78 Thousand | -686.95 Thousand | -59.08 Thousand | -85.15 Thousand |
| Interest Expense | 21.89 Thousand | 21.4 Thousand | 22.13 Thousand | 59.44 Thousand | 15.94 Thousand | 14.06 Thousand |
| Income Tax Expense | -13.01 Thousand | - | -100.65 Thousand | 442.44 Thousand | -44.78 Thousand | 60.91 Million |
| Earnings before Tax | -130.12 Thousand | -122.47 Thousand | -349.76 Thousand | 1.15 Million | -325.02 Thousand | -99.21 Thousand |
| Net Income | -117.1 Thousand | -122.47 Thousand | -349.76 Thousand | 1.02 Million | -280.24 Thousand | -99.21 Thousand |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.10 | - | -0.08 | -0.03 |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.10 | - | -0.08 | -0.03 |
| Weighted Average Shares Outstanding | 4.21 Million | 3.94 Million | 3.59 Million | 3.53 Million | 3.56 Million | 3.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.21 Million | 3.94 Million | 3.59 Million | 3.53 Million | 3.56 Million | 3.18 Million |
| Gross Margin | 0.62 | 0.71 | 0.75 | 0.75 | 0.75 | 0.75 |
| EBIT Margin | -1.83 | -1.71 | -2.08 | - | -5.21 | -1.44 |
| Profit Margin | -1.98 | -2.07 | -5.92 | 4.33 | -4.72 | -1.68 |
| EBITDA | -107.96 Thousand | -101.07 Thousand | -122.78 Thousand | - | -309.08 Thousand | -85.15 Thousand |
| Earnings Before Tax Margin | -1.83 | -1.71 | -2.08 | -2.90 | -1.00 | -1.44 |
KVM
8041
300808
GARPY
ARL
AUSS